Live Breaking News & Updates on Novel Biosignature Identified

Stay updated with breaking news from Novel biosignature identified. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DCISionRT by PreludeDx Identifies Women with DCIS with Unacceptably High Rates of Local Recurrence after Breast Conserving Surgery and Radiation Therapy

/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early stage breast cancer, presented data at the. ....

United States , Dan Forche , Andrew Wade , Cory Dunn , Frank Vicini , Prnewswire Prelude Corporation Preludedx , National Cancer Institute , American Society Of Clinical Oncology , Prelude Corporation , University Of California San Francisco , Clinical Oncology , Novel Biosignature Identified , Poor Biologic Subtype , Unacceptably High Rates , Local Recurrence , Breast Conserving Surgery , Low Risk , Elevated Risk , Response Subtype , Radiation Oncologist , California San Francisco , Know Your , Fjord Ventures , Decision Score , Know Your Risk , ஒன்றுபட்டது மாநிலங்களில் ,